The Impact of Opioids in Fractures - a Case Control Study
NCT ID: NCT02090972
Last Updated: 2016-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2014-03-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-fracture Medication and Mortality
NCT05366621
Fall, Fracture and Frailty
NCT05712252
Controlled Trial to Increase Detection and Treatment of Osteoporosis in Older Patients With a Wrist Fracture
NCT00175214
Osteoporosis and Colles Fracture
NCT00225004
Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.
NCT00725673
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with fracture
* fracture within the last 14 days
* no other fractures within the last 6 month
* patients \>60 years
No interventions assigned to this group
Control Patients
* patients hospitalized for an internal reason
* no other fractures within the last 6 month
* patients \>60 years
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
Exclusion Criteria
* troubles with memory, dementia or Parkinsons disease
* other fractures within the last 6 month
* alcoholised during the fall
* fracture older than 14 days
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mundipharma Research GmbH & Co KG
INDUSTRY
Ruhr University of Bochum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christoph Maier, Prof. Dr.
Prof., Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BG University Hospital Bergmannsheil, Ruhr University Bochum
Bochum, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FROP_BHL_Bochum
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.